Sign In
Buy TTI
$10.33
+0.0900 (+0.88%)
At Close: Jun 22, 2026
Thiogenesis Appoints Dr. Gilad Aharon to Its Board of Directors
08:00am, Wednesday, 17'th Jun 2026
San Diego, California--(Newsfile Corp. - June 17, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing
Can Viavi's New TETRA Testing Upgrade Strengthen Its Growth Story?
10:26am, Tuesday, 16'th Jun 2026
VIAV's new TETRA testing upgrade for the CX300 aims to speed deployments, cut costs, and reinforce its position in mission-critical radio testing.
VIAVI Launches TETRA MS Base Station Simulator Option for CX300 to Simplify and Speed Mission-Critical Radio Testing
06:30am, Monday, 15'th Jun 2026
Allows full testing of TETRA MS radios, including transmitter parametric measurements, call processing and BER/MER loopback without the need to place radios in T1 test mode CHANDLER, Ariz., June 15, 2
Is TETRA Technologies a Buy After An Insider Bought 22,000 Shares?
11:51am, Saturday, 13'th Jun 2026
Hallead acquired 22,000 shares on June 9, 2026, at a weighted average price of $9.86 per share, representing a transaction value of ~$217,000. This purchase increased his direct ownership by 14.79%, b
Thiogenesis Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of C$9.07 Million
06:00am, Wednesday, 03'rd Jun 2026
San Diego, California--(Newsfile Corp. - June 3, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing a next-generatio
TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock
12:00am, Wednesday, 03'rd Jun 2026
TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock PR Newswire SPRING, Texas, June 2,
TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock
11:36pm, Tuesday, 02'nd Jun 2026
SPRING, Texas, June 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) today announced the pricing of an underwritten public offering of 10,810,811 shares of its c
TETRA TECHNOLOGIES, INC. ANNOUNCES PUBLIC OFFERING OF COMMON STOCK
04:05pm, Tuesday, 02'nd Jun 2026
SPRING, Texas, June 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) today announced the commencement of an underwritten public offering of $100 million of share
Thiogenesis Upsizes Non-Brokered Private Placement of Common Shares
02:49pm, Monday, 01'st Jun 2026
San Diego, California--(Newsfile Corp. - June 1, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing
TETRA TECHNOLOGIES, INC. BOARD OF DIRECTORS APPROVES FINAL INVESTMENT DECISION FOR ARKANSAS BROMINE PRODUCTION FACILITY
05:30pm, Thursday, 28'th May 2026
Strong Project Economics and Growth Outlook With a Secure U.S. Bromine Supply SPRING, Texas, May 28, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) today announc
Thiogenesis Announces Non-Brokered Private Placement
09:00am, Monday, 11'th May 2026
San Diego, California--(Newsfile Corp. - May 11, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing a next-generatio
TETRA Technologies: Deep In The Oil Patch, A Critical Minerals Play Is Taking Shape
02:20am, Monday, 11'th May 2026
TETRA Technologies reported decade-high Q1 2026 revenue and EBITDA, with EPS coming 100% above estimates despite flat year-over-year growth. The company is constructing an Arkansas bromine facility fo
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
07:00am, Friday, 08'th May 2026
Topline results from healthy volunteer study and clinical development strategy for next-generation STAT3 inhibitor, TTI-109, anticipated in June Topline data from Phase 2 trial of TTI-101 in hepatoc
TETRA Technologies, Inc. (TTI) Q1 2026 Earnings Call Transcript
06:01pm, Thursday, 30'th Apr 2026
TETRA Technologies, Inc. (TTI) Q1 2026 Earnings Call Transcript
Tetra Technologies (TTI) Q1 Earnings and Revenues Top Estimates
07:41pm, Wednesday, 29'th Apr 2026
Tetra Technologies (TTI) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.11 per share a year ago.
